PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain
Status:
Completed
Trial end date:
2020-01-10
Target enrollment:
Participant gender:
Summary
A large number of studies have shown that patients feel more satisfied with hydromorphone in
the pain management. and a systematic review found that hydromorphone may be better suited
than morphine for titration of acute analgesia. However, current researches on intravenous
opioid titration for cancer pain such as hydromorphone are relatively insufficient in China.
Therefore, a prospective, multi-center, randomized controlled study is conducted to assess
the efficacy and safety of comparing patient-controlled analgesia (PCA) versus non-PCA
intravenous hydromorphone titration for severe cancer pain.